Test your knowledge of the July 2024 issue of AJMC with this quick quiz!
How can primary care provider turnover be reduced, according to a study conducted in the Veterans Affairs system?
FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy
November 22nd 2024The new drug application (NDA) includes data from a global placebo-controlled, 72-week study as well as findings from the STRIDE registry, an ongoing, observational, real-world study of ataluren in routine care.
Read More